Meetings & Events

Automated Insulin Delivery in the Management of T1DM

June 17, 2021

Session Date and Time:

Saturday, September 11
11:00–11:45 AM EDT

Learning Objectives:

  1. Review the strengths of hybrid closed loop technology.
  2. Summarize the weaknesses of hybrid closed loop technology.
  3. Identify patients who would benefit most from closed-loop technologies and those for whom it may not be appropriate.

Return to the full CEU 2021 program.

Register Now

Faculty Information

Anne L. Peters, MDDr. Peters is a Professor of Medicine at the Keck School of Medicine of USC and Director of the USC Clinical Diabetes Programs. Dr. Peters earned her medical degree from the Pritzker School of Medicine at the University of Chicago and performed an internal medicine residency at Stanford University and an endocrinology fellowship at Cedars-Sinai Medical Center. She previously directed the clinical diabetes programs at Cedars-Sinai and UCLA.

Her research has focused on testing new approaches for diagnosing and treating diabetes and developing systems of care to improve outcomes in diabetic populations. She has published over 200 articles, reviews, and abstracts, as well as three books on diabetes. She has been an investigator on over 40 research studies and has spoken at over 400 programs throughout the US as well as internationally.

She has served on many committees for the ADA and other organizations. Currently she is the chair of the Endocrine Society Committee on Diabetes Devices and is on the EASD/ADA Technology Safety Committee. Additionally she is a member of the JDRF Panel on Management of Exercise in Type 1 Diabetes. She is a member of the ABIM Endocrinology Subspecialty Board. She consults for many entities, including the FDA, Optum Rx and CVS/Caremark to help guide the development and use of treatments for diabetes.


Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.